China, India drugmakers must be cutting corners, says Teva Europe CEO; FDA finds fake Tamiflu via the Internet;

> Teva Europe's CEO Gerald Van Odijk says he wants regulators to conduct dawn raids on pharma plants in India and China because price analyses show that drugmakers there must be cutting corners. Article

> The FDA is warning consumers about Generic Tamiflu, sold over the Internet, which contains none of the real McCoy's active ingredient but instead a penicillin-like antibiotic. Article

> Swiss-based API maker Siegfried USA broke ground last week for a $1.5 million, 7,000-square-foot warehouse at its manufacturing plant in Pennsville Township, NJ. Article

> VeriPac 455 is a non-destructive inspection system for micro leak detection of empty and pre-filled syringes. Item

> TCP Reliable has set up a business unit to provide regulatory and cold chain compliance products to the US market. Release

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.